A

Ageas SA
OTC:AGESF

Watchlist Manager
Ageas SA
OTC:AGESF
Watchlist
Price: 69.95 USD Market Closed
Market Cap: $12.9B

Ageas SA
Investor Relations

Ageas SA, rooted in Belgium, traces its origins back to a rich history of transformation and amalgamation within the insurance industry. Initially part of the financial services conglomerate Fortis, the company shed its banking operations in the wake of the 2008 financial crisis to emerge as a pure insurance entity. Today, Ageas has grown into a notable international player, concentrating its expertise across Europe and Asia with a diverse array of offerings including life and non-life insurance, employee benefits, and reinsurance. This strategic focus allows Ageas to leverage its deep-seated insurance competencies, aiming to secure and enhance the financial wellbeing of its customers against various uncertainties.

The company thrives by generating revenue primarily through two avenues: underwriting operations and investment activities. In its underwriting operations, Ageas meticulously assesses and manages risks, collecting premiums from policyholders in exchange for insurance protection, ranging from life coverage to property and casualty insurance. Concurrently, Ageas employs a prudent investment strategy, investing premium income into a carefully selected portfolio of assets to generate returns. This dual-income approach ensures continued profitability and financial stability, enabling Ageas to navigate market fluctuations while safeguarding the interests of its stakeholders. By consistently refining its risk management frameworks and capitalizing on growth opportunities in both mature and emerging markets, Ageas solidifies its position as a stalwart in the global insurance landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2023
Call Date
Feb 28, 2024
Q4 2023 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls
2021
2020
2019
2018

Management

Mr. Bart Karel August De Smet
Exec. Chairman
No Bio Available
Mr. Hans J. J. De Cuyper
CEO & Exec. Director
No Bio Available
Mr. Christophe Boizard
CFO & Exec. Director
No Bio Available
Mr. Antonio Cano Y Bosque
MD of Europe & Exec. Director
No Bio Available
Mr. Emmanuel Van Grimbergen
Chief Risk Officer & Exec. Director
No Bio Available
Mr. Filip Andre Lodewijk Coremans
MD of Asia & Exec. Director
No Bio Available
Ms. Veerle Verbessem
Group Director Investor Relations
No Bio Available
Jerry Bata
Head of Legal
No Bio Available
Mr. Steven Georges Leon Braekeveldt
Chief Exec. Officer of Portugal
No Bio Available
Mr. Gary Lee Crist
Chief Exec. Officer of Asia
No Bio Available

Contacts

Address
BRUXELLES-CAPITALE
Brussels
Rue du Marquis 1 Boite 7
Contacts
+3225575711.0
www.ageas.com